-
Mashup Score: 28Contribution of an under-recognized adversity to child health risk: large-scale, population-based ACEs screening. - 8 day(s) ago
Background and Objectives: Whereas adverse early life experiences (ACEs) correlate with cognitive, emotional and physical health at the population level, existing ACEs screens are only weakly predictive of outcomes for an individual child. This raises the possibility that important elements of the early-life experiences that drive vulnerability and resilience are not being captured. We previously demonstrated that unpredictable parental and household signals constitute an ACE with cross-cultural relevance. We created the 5-item Questionnaire of Unpredictability in Childhood (QUIC-5) that can be readily administered in pediatric clinics. Here, we tested if combined screening with the QUIC-5 and an ACEs measure in this real-world setting significantly improved prediction of child health outcomes. Methods: Leveraging existing screening with the Pediatric ACEs and Related Life Events Screener (PEARLS) at annual well-child visits, we implemented QUIC-5 screening in 19 pediatric clinics span
Source: www.medrxiv.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 13
Background Primary prevention of cardiovascular disease relies on accurate risk assessment using scores such as the Pooled Cohort Equations (PCE) and PREVENT. However, necessary input variables for these scores are often unavailable in the electronic health record (EHR), and information from routinely collected data (e.g., non-contrast chest CT) may further improve performance. Here, we test whether a risk prediction model based on structural features of the heart and aorta from chest CT has added value to existing clinical algorithms for predicting major adverse cardiovascular events (MACE). Methods We developed a LASSO model to predict fatal MACE over 12 years of follow-up using structural radiomics features describing cardiac chamber and aorta segmentations from 13,437 lung cancer screening chest CTs from the National Lung Screening Trial. We compared this radiomics model to the PCE and PREVENT scores in an external testing set of 4,303 individuals who had a chest CT at a Mass Gener
Source: www.medrxiv.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 44An empirical cross-sectional analysis of the corrections in the New York Times’ COVID-19 coverage - 27 day(s) ago
Background To examine the errors and corrections in the New York Times (NYT) and to assess if there is an imbalance towards overstating the pandemic severity, which may support more extreme restrictions or understating the severity. Methods We conducted a retrospective cross-sectional analysis of COVID-19 articles that had corrections made and reported in the NYT “corrections page”. We categorized authors in a NYT COVID-19 article as a NYT reporter, NYT other, or independent author. We calculated the number and type of corrections by author type (NYT reporter, NYT other, and independent author) and number and percentage of corrections indicating an over- or under-statement of the COVID-19 situation. Results There were 576 total corrections for the included 486 articles. Forty-three percent (n=245) corrections specifically pertained to COVID-19. Compared to corrections not pertaining to COVID-19, corrections pertaining to COVID-19 were less likely to be about spelling (0% vs 23.6%), loc
Source: www.medrxiv.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial - 1 month(s) ago
Importance The effect of metformin on reducing symptom duration among outpatient adults with coronavirus disease 2019 (COVID-19) has not been studied. Objective Assess metformin compared with placebo for symptom resolution during acute infection with SARS-CoV-2. Design, Setting, and Participants The ACTIV-6 platform evaluated repurposed medications for mild to moderate COVID-19. Between September 19, 2023, and May 1, 2024, 2991 participants age ≥30 years with confirmed SARS-CoV-2 infection and ≥2 COVID-19 symptoms for ≤7 days, were included at 90 US sites. Interventions Participants were randomized to receive metformin (titrated to 1500 mg daily) or placebo for 14 days. Main Outcomes and Measures The primary outcome was time to sustained recovery (3 consecutive days without COVID-19 symptoms) within 28 days of receiving study drug. Secondary outcomes included time to hospitalization or death; time to healthcare utilization (clinic visit, emergency department visit, hospitalization, or
Source: www.medrxiv.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Deleterious coding variation associated with autism is consistent across populations, as exemplified by admixed Latin American populations - 1 month(s) ago
The past decade has seen remarkable progress in identifying genes that, when impacted by deleterious coding variation, confer high risk for autism spectrum disorder (ASD), intellectual disability, and other developmental disorders. However, most underlying gene discovery efforts have focused on individuals of European ancestry, limiting insights into genetic risks across diverse populations. To help address this, the Genomics of Autism in Latin American Ancestries Consortium (GALA) was formed, presenting here the largest sequencing study of ASD in Latin American individuals (n>15,000). We identified 35 genome-wide significant (FDR < 0.05) ASD risk genes, with substantial overlap with findings from European cohorts, and highly constrained genes showing consistent signal across populations. The results provide support for emerging (e.g., MARK2, YWHAG, PACS1, RERE, SPEN, GSE1, GLS, TNPO3, ANKRD17) and established ASD genes, and for the utility of genetic testing approaches for deleterious
Source: www.medrxiv.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3
Background: Artificial intelligence (AI) tools are increasingly used in breast imaging and radiology more broadly. Patients express varying levels of trust and acceptance toward the incorporation of AI tools, although no research has examined how it can best be communicated in the patient portal setting. Methods: English-speaking US women with 1+ prior mammogram were recruited via Prolific and randomized to one of thirteen conditions. All participants were shown a vignette asking them to imagine receiving a BI-RADS 1 (Negative) radiologist report from their patient portal. Participants in twelve conditions also received an AI report with one of four AI abnormality scores (not flagged: 0, 29; flagged: 31, 50) and 0-2 accompanying features (nothing; a only; a & b): (a) an abnormality cutoff threshold; (b) the AI tool’s False Discovery Rate (FDR) or False Omission Rate (FOR). As the primary outcome, participants indicated whether they would consider a lawsuit if a one-year follow-up found
Source: www.medrxiv.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 403COVID-19 Reproduction Numbers and Long COVID Prevalences in California State Prisons - 2 month(s) ago
Prisons have been hotspots for COVID-19 and likely an important driver of racial disparity in disease burden. From the first COVID-19 case detected through March 25, 2022, 66,684 of 196,652 residents of California’s state prison system were infected, most of them in two large winter waves of outbreaks that reached all 35 of the state prisons. We used individual-level data on disease timing and nightly room assignments in these prisons to reconstruct locations and pathways of transmission statistically, and from that estimated reproduction numbers, locations of unobserved infection events, and the subsequent magnitude and distribution of long COVID prevalence. Where earlier work has recommended smaller cells over large dormitory housing to reduce transmission, recommended use of cells with solid doors over those with bars only, and cautioned against reliance on solid doors (e.g., in cold months when HVAC systems can circulate aerosols), we found evidence of substantial transmission in b
Source: www.medrxiv.orgCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 93Overall Health Effects of mRNA COVID-19 Vaccines in Children and Adolescents A Systematic Review and Meta-Analysis - 2 month(s) ago
Importance Phase 3 randomized controlled trials (RCTs) of mRNA COVID-19 vaccines in children and adolescents showed efficacy in preventing COVID-19 infections. Vaccines may have non-specific effects. Objective Conduct a systematic review and meta-analysis of the phase 3 trials to assess overall and non-specific health effects of the mRNA COVID-19 vaccines. Data Sources PubMed, Embase, Clinical Trials, Web of Science, and regulatory websites were searched for RCTs of mRNA vaccines. The latest trial data was included. Study Selection All RCTs conducted with mRNA vaccines BNT162b2 and mRNA-1237 in children and adolescents below 18 years, with placebo, adjuvant, or other vaccines as controls. 1199 studies were screened; six were included in the analysis. Data Extraction and Synthesis Data on serious adverse events (“SAEs”) and severe adverse events (“Severe AEs”) as well as organ-specific diseases was extracted following the PRISMA reporting guideline, with a focus on non-specific infectio
Source: www.medrxiv.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
Background Continuous glucose monitors (CGMs) are being used to characterize postprandial glycemic responses and thereby provide personalized dietary advice to minimize glycemic excursions. However, the efficacy of such advice depends on reliable CGM responses. Objective To explore within-subject variability of CGM responses to duplicate meals in an inpatient setting. Methods CGM data were collected in two controlled feeding studies ([NCT03407053][1] and [NCT03878108][2]) in 30 participants without diabetes capturing 1056 meal responses in duplicate ∼1 week apart from four dietary patterns. One study used two different CGMs (Abbott Freestyle Libre Pro and Dexcom G4 Platinum) whereas the other study used only Dexcom. We calculated the incremental area under the curve (iAUC) for each 2-h post-meal period and compared within-subject iAUCs using the same CGM for the duplicate meals using linear correlations, intra-class correlation coefficients (ICC), Bland-Altman analyses, and compared in
Source: www.medrxiv.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Introduction: More than 150,000 women die worldwide every year of Triple-Negative Breast Cancer (TNBC). There are a range of treatment options, but no good way to match patients to their optimal treatment. For most newly diagnosed patients with early TNBC, the current standard of care is neoadjuvant chemo/immunotherapy before surgery, with patients who achieve a pathological complete response (pCR) having a better prognosis. We have developed a Functional Precision Medicine (FPM) test that uses a fresh biopsy, dissociates the cells, embeds them in a 3D hydrogel matrix, cultures them in a microfluidics device and tests them against a range of systemic therapies, while using a computer vision pipeline to measure responses to therapies ex vivo. Methods: We designed and conducted an observational multi-centre clinical trial to assess the feasibility of using our FPM assay in patients with newly diagnosed TNBC undergoing neoadjuvant therapy. Patients underwent an additional core needle biop
Source: www.medrxiv.orgCategories: General Medicine News, Oncologists1Tweet
Breaking silence to share our translational study in >30,000 kids. Showing unpredictable signal patterns from parents and environment are an early-life adversity and a major for depression https://t.co/CmzvEkmu3Z @dylanggee @CAPublicHealth https://t.co/eXzsGwHeT5